Anti-cytokine theraphy for Kawasaki disease
Latest Information Update: 23 Mar 2022
Price :
$35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Coronary artery disease; Mucocutaneous lymph node syndrome
- Focus Adverse reactions; Therapeutic Use
- 22 Mar 2022 Status changed from recruiting to discontinued.
- 06 Jan 2014 New trial record